Get started
Genetic Signatures Ltd.Genetic Signatures Ltd.Genetic Signatures Ltd.

Genetic Signatures Ltd.

No trades
No trades
OverviewFinancialsDocumentsNewsCommunityTechnicalsForecastsSeasonals

Financial actuals and estimates


Explore reported financial data and analyst estimates across the income statement, balance sheet, cash flow statement, and valuation metrics. Compare actual results with average, high, and low estimates, and visualize trends over time.
Income statementBalance sheetCash flow
Disclaimer
This is not investment advice and doesn't take into account your personal circumstances. It isn't a recommendation to buy, sell, or hold any asset. See the Terms of Use and always do your own research.

Frequently asked questions


The current price of GSS is 0.059 AUD — it has increased by 1.72% in the past 24 hours. Watch Genetic Signatures Ltd. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on ASX exchange Genetic Signatures Ltd. stocks are traded under the ticker GSS.
GSS stock has risen by 1.72% compared to the previous week, the month change is a −7.81% fall, over the last year Genetic Signatures Ltd. has showed a −80.97% decrease.
GSS reached its all-time high on Jul 28, 2020 with the price of 2.872 AUD, and its all-time low was 0.051 AUD and was reached on Aug 3, 2026. View more price dynamics on GSS chart.
See other stocks reaching their highest and lowest prices.
GSS stock is 7.27% volatile and has beta coefficient of 0.95. Track Genetic Signatures Ltd. stock price on the chart and check out the list of the most volatile stocks — is Genetic Signatures Ltd. there?
Today Genetic Signatures Ltd. has the market capitalization of ‪13.17 M‬, it has decreased by −1.64% over the last week.
Yes, you can track Genetic Signatures Ltd. financials in yearly and quarterly reports right on TradingView.
Genetic Signatures Ltd. is going to release the next earnings report on Aug 24, 2026. Keep track of upcoming events with our Earnings Calendar.
Genetic Signatures Ltd. revenue for the last half-year amounts to ‪8.70 M‬ AUD, despite the estimated figure of ‪9.50 M‬ AUD. In the next half-year revenue is expected to reach ‪9.60 M‬ AUD.
GSS net income for the last half-year is ‪−6.37 M‬ AUD, while the previous report showed ‪−4.90 M‬ AUD of net income which accounts for 0.00% change. Track more Genetic Signatures Ltd. financial stats to get the full picture.
No, GSS doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Genetic Signatures Ltd. EBITDA is ‪−15.87 M‬ AUD, and current EBITDA margin is −100.36%. See more stats in Genetic Signatures Ltd. financial statements.
Like other stocks, GSS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Genetic Signatures Ltd. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Genetic Signatures Ltd. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Genetic Signatures Ltd. stock shows the sell signal. See more of Genetic Signatures Ltd. technicals for a more comprehensive analysis.